Vaxxas Pty Ltd

Brisbane, Queensland, Australia
Purpose
to fund the pre-clinical development of Nanopatch microarray patch technology for the delivery of measles rubella vaccine, with the aim of overcoming gaps in measles rubella vaccine coverage particularly in low and middle-income countries
Grantee
Division
Global Development,
Global Health
Date
NOVEMBER 2016
Region served
GLOBAL
Committed amount
$4,398,315
Grant topic
Discovery and Translational Sciences,
Pneumonia & Pandemic Preparedness,
Vaccine Delivery
Duration (months)
43
Grantee location
Brisbane, Queensland, Australia
Related work

More about our financials

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.